Emerging Technologies Guide: November 2024
Recent new and emerging technologies in the field of laboratory medicine from the 2024 November Genetics & Genomics issue of Today's Clinical Lab
Today’s Clinical Lab is a reader-centric publication that keeps clinical professionals up to date with today’s rapidly changing lab industry with in-depth and timely editorial content and resources, including clinical industry news and insights into the latest trends, technologies, and techniques in the clinical lab.
ViewFull ProfileLearn about ourEditorial Policies.
INTEGRA Biosciences is excited to announce the launch of its MAG and HEATMAG modules for efficient, automated magnetic bead purification. These innovative solutions allow researchers to streamline several processing steps in molecular biology and proteomics workflows for maximum lab throughput. These time-saving devices are complemented by the COLDPLATE and BIOSHAKE—for precise temperature control and orbital shaking of magnetic beads, respectively—to further streamline protocols.
Hamilton's innovative Verso Dx is an automated postanalytical storage system that caters to different workflows thanks to its ability to load samples either manually or via lab track. This flexible system, which can be built in multiple sizes, features a storage capacity ranging from 30,000 to 1 million tubes. The platform can store tubes at ambient or the common temperature of 5°C, while also boasting the capability to store samples at -20°C for special applications.
Streamline Your Clinical PCR Workflows with QIAcuityDx
QIAcuityDx is tailored for IVD applications. This fully automated digital PCR system enhances diagnostic precision and operational efficiency by reducing hands-on time and ensuring accurate detection and quantification of important genetic variations. Easily develop your own assay menu* by using QIAcuityDx utility mode and IVD medical device consumables, reagents, and software.
*FDA ‘Medical Devices; Laboratory Developed Tests’ final rule, May 6, 2024 and European Union regulation requirements on ‘In-House Assays’ (Regulation (EU) 2017/746 -IVDR- Art. 5(5)) The QIAcuityDx dPCR System is intended for in vitro diagnostic use, using automated multiplex quantification dPCR technology, for the purpose of providing diagnostic information concerning pathological states. QIAcuity and QIAcuityDx dPCR instruments are sold under license from Bio-Rad Laboratories, Inc. and exclude rights for use with pediatric applications.